A NEW APPROACH TO THE TREATMENT OF WOMEN OF REPRODUCTIVE AGE WITH ADENOMYOSIS

This paper focuses on women of reproductive age with adenomyosis and investigates a novel minimally invasive integrative treatment combining intrauterine hormonal delivery, phytotherapy, and platelet-rich plasma (PRP) with the goal of improving symptom relief, quality of life, and reproductive outcomes. The authors frame adenomyosis as a chronic condition involving ectopic endometrial tissue within the myometrium and note that standard options like hormonal therapy and surgery may be inadequate or unsuitable for fertility-preserving patients. The paper’s main caveat is that it is presented as an exploration of a new approach rather than detailing comparative evidence in the provided text. This paper is centrally about adenomyosis — it specifically proposes and evaluates an integrative intrauterine hormonal delivery plus phytotherapy and PRP treatment strategy for reproductive-age women.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works